Litigation raises execution risk and may compress near-term revenue and margin for Coty while strengthening Kering’s leverage to optimize Gucci Beauty’s long-run positioning with L’Oréal, with brand equity outcomes hinging on a tightly managed, compensated transition.
Coty has filed a UK lawsuit against Kering and Gucci over the Gucci Beauty license, which is set to transfer to L’Oréal under a 50-year exclusive deal starting in 2028. With Gucci contributing an estimated 8% of Coty sales and 11% of profit, litigation introduces execution risk to transition planning, capital allocation, and retailer confidence, potentially altering timing and economics of any early exit or handover.
Next 30–90 days: heightened legal costs and management distraction; retailers and suppliers may pause or condition 2026–2028 commitments; Coty likely rebalances A&P toward non-Gucci hero franchises while safeguarding Q4 holiday sell-out; Kering and L’Oréal accelerate transition workstreams under stricter legal clean rooms and documentation.
Prestige beauty remains one of luxury’s most resilient categories, outgrowing soft luxury with high-single-digit global growth even as China’s discretionary spend moderates and US traffic normalizes. Consolidation of fashion-fragrance under mega-houses like L’Oréal and Estée Lauder is increasing retailer bargaining power and shelf-space compression, raising stakes for innovation cadence and A&P efficiency. Gen-Z momentum in fragrance and social-first discovery favors portfolios that can sustain rapid launch cycles and global media, advantaging L’Oréal if Gucci migrates; Coty must counter by focusing on hero franchises and travel retail strength while navigating sustainability packaging mandates in the EU that complicate rapid reformulations and transfers.